The global infertility treatment market size will reach USD 7 billion in 2025, growing at a CAGR of 6% during the forecast period. The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide. Hence, the treatment is likely to grow at a healthy rate due to attractive long-term growth from favorable demographics and social/cultural shifts.
Over the past few years, the infertility treatment market has been growing at a healthy rate. This growth is due to the growing awareness of several medical care options, IVF procedures, and the surge in fertility tourism. The popularity of same-sex marriage in the US increases the adoption of several assisted reproductive technology (ART) procedures.
The rise in the obese population is also positively influencing the growth of infertility treatment. Obesity might lead to ovulation disorder, imbalance in hormones, and, eventually, result in infertility. This increase in infertility has contributed to driving market growth globally.
- The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market.
- The globalization of healthcare facilities and the increasing popularity of fertility tourism. This is encouraging several couples to travel abroad to seek state-of-the-art medical care options.
- The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs.
- Most fertility service providers offer discounted programs and flexible payment options. These are promotional initiatives, promoting savings on expensive procedures to self-pay patients.
- The growing popularity of fertility tourism is expected to increase the demand for medical procedures in countries where the cost is low and success rates are high, thereby driving the segment.
INFERTILITY TREATMENT MARKET SEGMENTATION
This research report includes detailed segmentation by
INSIGHTS BY PRODUCT
Treatment by drugs has been dominating the infertility treatment market share. This method is a cost-effective measure and is considered the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly. It is likely to witness steady growth during the forecast period.
Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing. The increasing effectiveness of ART procedures and surgical interventions creates a huge demand for consumables. Therefore, the consumables segment is expected to grow by 2024.
INSIGHTS BY PROCEDURE
The medication market segment accounted for a market share of 73% in 2018. The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication.
ART is the fastest growing procedure. The high acceptance rate is because of the improvement in success rate and advanced techniques to cure sterility. ART procedures include different procedures like artificial insemination, in-vitro fertilization IVF, surrogacy, and others. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.
The surgical interventions segment is expected to witness gradual growth by 2024. Surgical interventions are considered as the second line of care after medication. This segment is likely to see an incremental growth of around $200 million during the forecast period.
INSIGHTS BY END-USER
Fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility centers is expanding across the globe. These clinics occupy the largest share in the infertility treatment market.
Fertility centers offer different services, such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period. This is due to the constant rise in clinics and increasing partnership of clinics with fertile consultants and experts.
Hospitals are a significantly fast-growing segment. They provide traditional medical care, such as fertility medicines, drugs, prescriptions, and surgeries. They also facilitate procedures such as IVF and ART, which are likely to have significant demand during the forecast period.
Gynecologists and urologist clinics offer high-quality women’s healthcare services, including labor care, and prescribe medication for fertility treatment. They are primary healthcare centers performing preliminary fertility evaluations among end-users. Hence, this segment is expected to grow at a steady growth during the forecast period.
INSIGHTS BY CAUSES
The female segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing fertility clinics are the major factors driving the growth. The rise in the number of obese women is likely to increase the demand for various fertility treatment options.
The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns. Increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity are the responsible factors. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.
INSIGHTS BY GEOGRAPHY
Europe is leading the market and is expected to bolster its dominance during the forecast period. The region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. Spain, France, Germany, the UK, and Italy are the leading revenue generators. The region will witness an incremental growth of around $600 million during the forecast period.
The demand for fertility services is increasing rapidly in North America. The rise is due to the growing prevalence of sterility, the presence of the aging population, and obesity. These factors are likely to generate significant demand for fertility services in the future.
APAC is growing at a steady pace. The shifting mean age among women during their first childbirth and the increasing sterility is driving the market growth. Japan, Australia, China, and India are the major revenue contributors in the APAC region. This region is likely to witness the highest incremental revenues during the forecast period.
Latin America is witnessing a rise in sterility among men and women. The decreasing fertility rates in the population is likely to increase the demand for fertility services. The region is growing at a moderate pace, which is likely to continue during the forecast period.
MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, the growing awareness and development of advanced technology are expected to drive the infertility treatment market share in the region.
INSIGHTS BY VENDORS
There are a few global and several local and regional key players offering medicines, devices, and treatment equipment. The fertility drug market is highly concentrated, with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented. Many local and domestic companies are offering a wide array of low-cost drugs in their respective countries.
The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.
Cooper Companies offers its infertility treatment products through the CooperSurgical business segment. Cooper is focusing on specific segments of women’s health care market and is the market leader. Its major competitors in the market include Cook, Irvine Scientific, and Vitrolife.
The global infertility treatment market research report includes revenues & forecasts for the following segments:
- Other Drugs
- Drug Therapy
- ART Procedure
- Surgical Intervention
- Gynecological & Urology Clinics
- North America
- South Korea
- Latin America
- Middle East & Africa